Dexmethylphenidate 7.8 mg / serdexmethylphenidate 39.2 mg Oral Capsule
RxNorm 2562191
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 2562191 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: dexmethylphenidate 7.8 mg / serdexmethylphenidate 39.2 mg Oral Capsule.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SCDPrescribable
Semantic Clinical Drug (SCD):
Dexmethylphenidate 7.8 mg / serdexmethylphenidate 39.2 mg Oral Capsule
(Atom ID: 12654051)
SYPrescribable
Synonym (SY):
Dexmethylphenidate 7.8 mg (as dexmethylphenidate hydrochloride 9 mg) / serdexmethylphenidate 39.2 mg (as serdexmethylphenidate chloride 42 mg) Oral Capsule
(Atom ID: 12654062)
PSNPrescribable
Prescribable Name (PSN):
Dexmethylphenidate 7.8 mg / serdexmethylphenidate 39.2 mg Oral Capsule
(Atom ID: 12654061)
Patient Education
Serdexmethylphenidate and Dexmethylphenidate
The combination of serdexmethylphenidate and dexmethylphenidate is used as part of a treatment program to control symptoms of attention deficit hyperactivity disorder (ADHD; more difficulty focusing, controlling actions, and remaining still or quiet than other people who are the same age) in adults and children 6 years of age and older. The combination of serdexmethylphenidate and dexmethylphenidate is in a class of medications called central nervous system stimulants. These medications work by changing the amounts of certain natural substances in the brain.
[Learn More]
* Please review the disclaimer below.